Sana Biotechnology, Inc.
Sana Biotechnology, Inc. scores highest on Earnings (48) and lowest on Price (15). Its PosiPenta is 30.63 out of 100, weaker than most similar companies.
On the Penta Grid this week, Sana Biotechnology, Inc. is Grid #753 of 837 in the Healthcare sector in United States, and Grid #3,585 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Sana Biotechnology, Inc. | 30.63 | 15 | 48 | 23 | 25 | 42 |
| Cytek Biosciences, Inc. | 58.94 | 28 | 71 | 84 | 59 | 54 |
| Sagimet Biosciences Inc. | 47.34 | 26 | 33 | 72 | 70 | 35 |
| The Oncology Institute, Inc. | 65.20 | 0 | 68 | 92 | 99 | 68 |
| Annexon, Inc. | 35.17 | 19 | 36 | 45 | 38 | 38 |
| Iambic Therapeutics, Inc. | 44.33 | 0 | 26 | 94 | 64 | 38 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -2.99 |
| P/B ratio | 4.40 |
EEarnings
| Trailing EPS | ₹-71.98 |
| Forward EPS | ₹-52.58 |
NNitro
| Price | 215.00 |
| 52-week high | 558.82 |
| 52-week low | 213.11 |
| Fall from 52-week high | 61.5% |
TTorque
| Return on equity (ROE) | -152.87% |
| Debt-to-equity | 0.52 |
AAnchor
| Beta (price swings) | 2.19 |
| Market cap | ₹6,436 Cr |
| Insider holding | 6.08% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Sana Biotechnology, Inc.'s PosiPenta score?
Sana Biotechnology, Inc.'s PosiPenta is 30.63 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Sana Biotechnology, Inc. stand on the Penta Grid?
On the Penta Grid this week, Sana Biotechnology, Inc. is Grid #753 of 837 in the Healthcare sector in United States, and Grid #3,585 of 4,000 in United States.
Which PosiPenta pillar is strongest for Sana Biotechnology, Inc.?
Earnings (growth), with a score of 48 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Sana Biotechnology, Inc.?
Price (valuation), with a score of 15 out of 100: much weaker than most similar companies.
Has Sana Biotechnology, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.50 points, from 27.13 to 30.63.
PositoAI is for research and education only and is not investment advice.